An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
908 Devices Inc. (Nasdaq: MASS) will report its first quarter 2024 financial results on April 30, 2024. The company specializes in handheld and desktop devices for chemical and biochemical analysis. The conference call will be webcasted at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time, with live audio available on their website. The webcast will be archived for replay within 24 hours.
908 Devices Inc. (Nasdaq: MASS) annuncerà i risultati finanziari del primo trimestre del 2024 il 30 aprile 2024. L'azienda è specializzata in dispositivi portatili e da tavolo per l'analisi chimica e biochimica. La teleconferenza sarà trasmessa in streaming alle 8:30 ora della costa orientale / 5:30 ora della costa pacifica, con l'audio disponibile in diretta sul loro sito web. La trasmissione sarà archiviata per la riproduzione entro 24 ore.
908 Devices Inc. (Nasdaq: MASS) informará sobre sus resultados financieros del primer trimestre de 2024 el 30 de abril de 2024. La compañía se especializa en dispositivos portátiles y de escritorio para análisis químico y bioquímico. La llamada de conferencia será transmitida en la web a las 8:30 a.m. hora del Este / 5:30 a.m. hora del Pacífico, con audio en vivo disponible en su sitio web. El webcast se archivará para su reproducción dentro de las 24 horas.
908 Devices Inc. (나스닥: MASS)는 2024년 4월 30일에 2024년도 1분기 재무 결과를 보고할 예정입니다. 이 회사는 화학 및 생화학 분석을 위한 휴대용 및 데스크탑 장치를 전문으로 합니다. 회의 전화는 동부 표준시 오전 8:30 / 태평양 표준시 오전 5:30에 웹캐스트로 방송될 예정이며, 생방송 오디오는 웹사이트에서 제공됩니다. 웹캐스트는 24시간 내에 다시 보기를 위해 보관됩니다.
908 Devices Inc. (Nasdaq: MASS) présentera ses résultats financiers pour le premier trimestre de 2024 le 30 avril 2024. L'entreprise est spécialisée dans les appareils portables et de bureau pour l'analyse chimique et biochimique. La conférence téléphonique sera diffusée sur le Web à 8h30, heure de l'Est / 5h30, heure du Pacifique, avec un audio en direct disponible sur leur site Web. La webdiffusion sera archivée pour rediffusion dans les 24 heures.
908 Devices Inc. (Nasdaq: MASS) wird seine Finanzergebnisse für das erste Quartal 2024 am 30. April 2024 bekannt geben. Das Unternehmen ist spezialisiert auf Handgeräte und Desktop-Geräte für chemische und biochemische Analysen. Der Telefonkonferenz wird am 30. April um 8:30 Uhr Ostküstenzeit / 5:30 Uhr Pazifikzeit online übertragen, wobei die Live-Audioübertragung auf ihrer Webseite verfügbar sein wird. Die Webübertragung wird innerhalb von 24 Stunden zur Wiedergabe archiviert.
Positive
None.
Negative
None.
Insights
Analyzing the forthcoming disclosure of 908 Devices' financial results for the first quarter of 2024, investors should consider several key factors that typically influence the financial health and stock performance of a company. Revenue growth, profit margins, costs and earnings per share are critical indicators that can sway investors' confidence and thus the stock price.
Revenue growth, especially for a pioneering tech company like 908 Devices, reflects its ability to monetize innovations and capture market share. Profit margins will inform us on how efficiently the company is managing its production costs and operating expenses against its revenues. Any significant deviation from the industry norms in these metrics could indicate strategic successes or challenges.
Investors should also monitor the company's forward-looking statements for any guidance on future revenues or earnings. Developments such as expanding product lines, strategic partnerships, or entry into new markets could potentially alter the company's trajectory and are essential components of the investment thesis.
From a market perspective, assessing the competitive landscape and market trends that 908 Devices operates within is crucial. The demand for chemical and biochemical analysis devices is influenced by factors such as regulatory changes, research and development in various industries and technological advancements.
It’s informative to compare the company’s performance with peers and to understand the market’s growth rate. If 908 Devices is growing faster than the market, it indicates a competitive advantage and potentially higher future market share. Conversely, if the company's growth is lagging, it might suggest the need for strategic realignment or innovation.
BOSTON--(BUSINESS WIRE)--
908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.908devices.com. The webcast will be archived and available for replay within 24 hours after the event.
About 908 Devices
908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.
